New England Private Wealth Advisors LLC Abb Vie Inc. Transaction History

New England Private Wealth Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $558,574 - $698,896	-7,744 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $1,889 - $2,271	30 Added 0.39%	7,744 $584,000
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $1,708 - $2,183	26 Added 0.34%	7,714 $563,000
Q1 2019 May 02, 2019	BUY	$77.14 - $90.79 $1,465 - $1,725	19 Added 0.25%	7,688 $620,000
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $51,614 - $63,654	663 Added 9.46%	7,669 $703,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $38,231 - $42,501	-430 Reduced 5.78%	7,006 $662,000
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $44,710 - $52,902	-498 Reduced 6.28%	7,436 $695,000
Q1 2018 May 04, 2018	BUY	$92.01 - $123.21 $33,859 - $45,341	368 Added 4.86%	7,934 $750,000
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $78,544 - $86,130	-877 Reduced 10.39%	7,566 $733,000
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $589,743 - $753,284	8,443	8,443 $752,000

3,843

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $294B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of New England Private Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on New England Private Wealth Advisors LLC with notifications on news.